Health Care, HIPAA, and Telemedicine Law

HB Ad Slot
HB Mobile Ad Slot

Healthcare law is constantly changing, especially in today’s data driven online world.  Healthcare providers have unprecedented concerns related to privacy and cybersecurity as different technologies and threats intersect in ways never seen before.  With the growth of cloud computing and electronic health records, more regulations and greater scrutiny has been given to the industry, as hospitals, medical providers and healthcare agencies are liable in new and different ways.

The National Law Review covers all legal aspects of the healthcare industry, with expert legal analysis on HIPAA regulations, non-profit organization status, to home health and nursing care abuse.   Additionally, the National Law Review covered all aspects of the Affordable Care Act, or Obamacare, and its implementation, as well as the various attempts to repeal the ACA and new legislation in the healthcare arena, including the American Health Care Act of 2017.

Visitors can read about the US Department of Health and Human Services (HHS), the Office for Civil Rights (OCR), and regulations being promulgated by the Food and Drug Administration (FDA). The Center for Medicare & Medicaid Services (CMS) is also frequently discussed as it relates to drug pricing plans and premiums, new insurance policy requirements and other industry norms.

A major issue in healthcare is the prominence of Ransomware attacks and other cybersecurity concerns, as they relate to patient protected information and HIPAA compliance.  Healthcare systems wanting to maintain compliance with HIPAA regulations and protect patient privacy can find legal analysis and information on how to do so.

Additionally, the rise of Telehealth initiatives in a variety of areas is another area covered by the National Law Review.  With these new technologies, there is a lot of opportunity for innovation, however, careful understanding of telehealth legislation, reimbursement policies and regulations is essential to maintain a standard of care and avoid litigation.

Hospice care, the opioid epidemic, Medicare reimbursement, and issues with antitrust when healthcare systems merge are among the news stories covered by the National Law Review.  Visitors will consistently find updated stories on regulating medical devices, new life sciences technologies, and legislative developments in the healthcare arena. Because the industry is ever-changing, the National Law Review always has new content related to healthcare law.

National Law Review Healthcare Law XFor hourly updates in the latest news about Healthcare & Health Management law, regulations, and legislation, be sure to follow our Health Law X (formerly Twitter) feed, and sign up here for our daily complimentary e-news bulletins.

Recent Health Care, Medicare, ACA, HIPAA & OIG Law News

Title
Custom text Organization
Dec
8
2023
OSHA Recommendations on COVID Are Not Enough to Qualify a Business for the Employee Retention Credit Miller Canfield
Dec
8
2023
Illinois Supreme Court: Finger-Scan Information Collected by Healthcare Providers to Access Medications Is Exempt From BIPA Liability McDermott Will & Emery
Dec
8
2023
HHS Publishes Roadmap of New Strategy for Cybersecurity in the Healthcare Sector Proskauer Rose LLP
Dec
8
2023
Ninth Circuit: Health Insurance Opt-Out Fees Not Part of Regular Rate for Overtime Purposes Jackson Lewis P.C.
Dec
7
2023
What to Expect in Evolving U.S. Regulation of Artificial Intelligence in 2024 Foley & Lardner LLP
Dec
7
2023
Win for Healthcare Institutions: Illinois High Court Rules Healthcare Employees’ Biometrics Exempt from BIPA Requirements Squire Patton Boggs (US) LLP
Dec
7
2023
The BR Privacy & Security Download: December 2023 Blank Rome LLP
Dec
7
2023
Policyholders Score Win as Another State’s High Court Adopts the “Continuous-Trigger” Theory for General Liability Policies Hunton Andrews Kurth
Dec
7
2023
No More Surprise Medical Bills: Biden Administration Issues New Surprise Billing Rulemaking Proposing Batching and Procedural Changes to Arbitration Process Under No Surprises Act ArentFox Schiff LLP
Dec
7
2023
Podcast: Telehealth Post-Public Health Emergency – What to Expect in 2024 – Diagnosing Health Care [Podcast] Epstein Becker & Green, P.C.
Dec
7
2023
Challenge to False Claims Act Qui Tam Provisions Fails in an Initial Attempt to Revive Long-Dormant Arguments as to Constitutionality Under Article II Mintz
Dec
7
2023
Chicago Employees to Receive 10 Days of Paid Leave McDermott Will & Emery
Dec
7
2023
A Timeline of Biden’s AI Executive Order — AI: The Washington Report Mintz
Dec
7
2023
California Privacy Protection Agency Proposes Draft Rules for Automated Decision Making, Including Artificial Intelligence K&L Gates
Dec
6
2023
Chicago Employees Entitled to Paid Leave: What Employers Should Know Chuhak & Tecson, P.C.
Dec
6
2023
OHCA Published Near-Final Draft of Regulations Requiring Notice and Review of Material Healthcare Transactions in 2024 Sheppard, Mullin, Richter & Hampton LLP
Dec
6
2023
Biden’s October 30, 2023, Executive Order on AI: Key Takeaways for Health Care Stakeholders Polsinelli PC
Dec
6
2023
White House OSTP and NNCO Announce Series of Events in Celebration of 20th Anniversary of the Authorization of the NNI Bergeson & Campbell, P.C.
Dec
6
2023
Decentralized Clinical Trials: Diversity in Clinical Trials Foley & Lardner LLP
Dec
6
2023
This Week in 340B: November 28 – December 5, 2023 McDermott Will & Emery
Dec
6
2023
FDA’s Final Rule on Direct-to-Consumer Advertising – Presentation of Risk Information Foley & Lardner LLP
Dec
5
2023
The Proposed MHPAEA Regulations: Comments on Behavioral Health Carve-Out Vendors McDermott Will & Emery
Dec
5
2023
Council On Supply Chain Resilience Tasked With Strengthening Domestic Supply Chains And Limiting Reliance On Foreign Medical Supplies Squire Patton Boggs (US) LLP
Dec
5
2023
Episode 30: Let’s Talk Compliance: Medical Device and Physician Arrangements [Podcast] Foley & Lardner LLP
Dec
5
2023
FDA Study Finds Biosimilars Are Interchangeable ArentFox Schiff LLP
Dec
5
2023
Unpacking Averages: Analyzing FDA Device-Related Citizens Petitions by Topic Epstein Becker & Green, P.C.
Dec
5
2023
Biden Administration Prioritizing Domestic Production of Pharmaceuticals . . . Again? Blank Rome LLP
Dec
5
2023
UK Business Immigration: Significant Hike in Visa Salary Thresholds Squire Patton Boggs (US) LLP
 

NLR Logo

We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up to receive our free e-Newsbulletins

 

Sign Up for e-NewsBulletins